Saturday, October 30, 2010

What Can U Use For Round Table Cloths 84 In

The Truth About Drugs Antidiabetic

Suspension of permission marketing antidiabetic drugs containing rosiglitazone (Avandia ®, Avandamet ®, Avaglim ®).






The European Medicines Agency (EMA) recommends suspension of authorizations to market-based drugs rosiglitazone (Avandia ®, Avandamet ®, Avaglim ®). This suspension follows the re-evaluation by the European Medicines Evaluation Human Use (CHMP) which concluded that the risk / benefit ratio was unfavorable due to the increased cardiovascular risk. The reassessment of recent data, announced last July, confirmed the increased cardiovascular risk, mainly the occurrence of myocardial infarction and stroke in relation to the expected benefits of reducing blood sugar.



Afssaps asks patients currently treated with a drug containing rosiglitazone not stop their treatment without seeking the advice of their doctor, and consult in the coming weeks to adjust their diabetes treatment. Right now, doctors should prescribe more drugs containing rosiglitazone.
Rosiglitazone belongs to a class of oral antidiabetic drugs, the glitazones used to treat type 2 diabetes for improved glycemic control and prevention of complications related to diabetic microangiopathy, affecting in particular the retina and kidney. Three specialties have an authorization for the European market: Avandia ® (rosiglitazone) in 2000, Avandamet ® (Rosiglitazone and metformin) in 2003 and Avaglim ® (rosiglitazone and glimepiride) in 2006. Only the first two drugs are marketed in France. Since the communication of Afssaps in January 2008, informing them of the restrictions on use of rosiglitazone in patients with ischemic heart disease, consumption of drugs containing rosiglitazone decreased by 50%. To date, approximately 110,000 patients are treated with rosiglitazone.
examination of all available data (meta-analysis, epidemiological studies and clinical trials) with rosiglitazone led the European Medicines Agency (EMA) to request the suspension of authorizations for the marketing of drugs containing this active ingredient. The revaluation undertaken at the request of the European Commission, concerned especially the cardiovascular risk of these drugs.
In 2008, an initial assessment had already led the European health authorities to restrict the use of rosiglitazone in patients with ischemic cardiovascular diseases, and this both for beginners as for continued treatment. Afssaps states that rosiglitazone is indicated in France in second-line after failure or intolerance other oral antidiabetic drugs.



Afssaps asks patients currently treated with a drug containing rosiglitazone not stop their treatment without seeking the advice of their doctor and consult in the coming weeks to adapt their antidiabetic . Now, doctors should prescribe more drugs containing rosiglitazone.

Source: http://www.afssaps.fr/


-> When will we tell the truth for diabetics? The fact that their illness is caused by a diet too rich in carbohydrate and too low in micronutrients!


... We must pass the Knowledge and Truth ... ...
Truth always ends up Know ...


DJAMELITO

Wednesday, October 20, 2010

20g Balsa Wood Bridge Designs

Alzheimer's: A red herring ...




... A promising drug does not keep its promises ...


Two studies were devoted in recent years a new drug, Semagacestat, designed to stop Alzheimer's disease. Unfortunately, it is ineffective and has adverse side effects. Research has been stopped.




In the case of Alzheimer's disease, plaques of proteins called beta-amyloid "accumulates in the brain. The assumption was, therefore, for many researchers, that these clusters were responsible for Alzheimer's disease and the drug, the subject of studies now discontinued, was just cut those famous plates. On this side, he played his role perfectly. The protein plaques were much diminished in the brains of patients affected by the studies. But these people have not seen their condition improve. Neither they nor their memory cognitive functions have received treatment and is the worst, their ability to perform everyday tasks has weakened further ...

For Dr. Judes Poirier, Quebec biochemist specializing in Alzheimer's disease, these results have surprising: "In mice as in the elderly, the presence of plaques of amyloid beta-protein is not associated with neuronal loss or loss of memory, even when the brain is full of amyloid.

Other hypotheses regarding the causes of Alzheimer's disease must be addressed if we want to find remedies.


Although there is no effective medication to treat Alzheimer's disease, a number of studies have shown that it is possible to slow its evolution

- According to research Brazilian scientists, some herbs such as lemon balm, sage and Ginkgo biloba in reducing symptoms associated with the disease.
- An active social and intellectual life (playing cards, doing crossword puzzles, meet friends, have a community life ...), food rich in omega 3 and regular exercise are all assets to also limit the influence of disease on quality of life.



... We must pass the Knowledge and Truth ... ...
Truth always ends up Know ...



DJAMELITO

Sunday, October 17, 2010

Pediatric Walk In Clinic Downtown Toronto

PLAN AIDS

Wednesday, February 6, the newspaper Liberation reported that " the entire French population aged 15 to 70 years, will be tested on AIDS, without obligation, as the AIDS Plan 2010-2014 that has just completed the Minister of Health, Roselyne Bachelot. In December, a national information campaign and called all healthcare professionals to offer this test to their patients. The ten thousand practitioners who have signed the "contract for improvement of individual practices (Capi) will probably 7 euros per year per patient and tested.


Our ambition is brilliant minister "to end this epidemic," as she had the ambition to "protect" all the French of the "terrible pandemic" of swine flu that threatened their lives . It must be said that the plan provides nearly one billion euros over five years, including the continuation of current measures, which is still less than the cost of his previous ambition. The project of "trivializing the screening towards the general population," including one that runs no risk, will only double the conventional screening and free already made in the health care system. It is unclear what may be his interest in the medical or financial.

This decision comes shortly after the declaration of Professor Luc Montagnier, Nobel Prize in Medicine for his discovery of HIV in the film, Brent Leung, House of numbers: "You can be exposed to HIV repeatedly without being chronically infected. " According to the words of Dr. Montagnier, which will benefit, hopefully, recognition granted by the Nobel Prize for popular misconceptions and denounce the prevailing dogma, with a good immune system, it is resistant to disease. AIDS can be combated by proper feeding, balanced, rich in antioxidants and a healthy living, "and all that can be easily implemented for a pittance."

These statements are very different from the discourse of pseudo-experts invited on the sets TV to terrorize listeners. In France, nearly 50,000 people live with HIV without knowing it, so without suffering. This indicates that despite their status, they can not be considered as AIDS. However, detection may be classified under one of these, and this classification can be likened to a conviction. Why induce in them the fear that undermines the immune system, whereas they are the best protection against any disease?

Certainly the words of Professor Montagnier on the immune system of the infected person, malaria, tuberculosis, intestinal parasites who are immunocompromised nutritional imbalance partly due to food quality industrial impoverished because of immunosuppression, may appeal to laboratories that advertise on the search for a vaccine and lucrative run covertly health authorities. Is this why our national Roseline beholden to the industry comes to her rescue as it did for the flu?


Sylvie Simon


Source: http://www.altermonde-sans-frontiere.com


... We must pass the Knowledge and Truth ... ... The
Truth will come to know ...


DJAMELITO

http://arnaquedusida.blogspot.com

Saturday, October 16, 2010

Diamonds Stones Brazilian Waxing

The Truth about a drug for diabetics: The Picks (derived from FLUORINE)



The plectrum (benfluorex) was marketed in France from 1975 to November 2009 , when he was finally banned by Afssaps through the struggles of a pulmonologist Brest Irene Frachon.



This book is the story of a fight to ban the 150 mg Picks: In November 2009, after a thorough investigation of several years, Irene Frachon, aided by fellow of the University Hospital of Brest, had contributed to the prohibition of the drug.

normally prescribed to treat diabetes which was taken by 300,000 patients in France, it was administered as an appetite suppressant to millions of people. However, it is not safe and can cause death: This medication may cause in some people, serious side effects. Brest physicians were able to prove that the Picks could lead to serious complications in heart valves or pulmonary hypertension. But also death.
Frachon Irene tells his investigation, his interventions Afssaps, its relations with the laboratory, which markets the drug, its discoveries.

Servier Laboratory (second after the French pharmaceutical group Sanofi-Aventis) was assigned an interim publisher (dialogues.fr-editions): This is just proof that the giant pharmaceutical royally fucks Health people indeed his only interest is profitability.

There are significant conflicts of interest, especially in the expert committees Afssaps. Agencies are not doing enough to sort out the independent experts and those who publish through the pharmaceutical industry Indeed, experts who have a conflict of interest should not participate in drug reviews.

I note that the pick is a derivative of FLUOR and the icing on the cake is a recent study has confirmed the dangers the pick, it is about a thousand dead (personally I would say several thousand).


I ask the pharmaceutical industry to stop developing drugs based Fluor, which only serve to recycle toxic waste become profitable.



... We must pass the Knowledge and Truth ...
... The truth will come to know ...



DJAMELITO

Wednesday, October 13, 2010

Patty Cake- In Training

The Truth About Mammography




The dark side of mammography


Everything you wanted to know about your mammogram without doctor dares to learn ...



Like every year at the same time - and without regard to the gradual depletion of our financial health insurance - that is left for the promotion of mammography. To hear the health authorities - relayed by the press and apparently the majority of the medical profession - the survival of most "women we love" [1] depend on this screening, it should be further intensified.



And, according to a dynamic of its own drive to all major religious causes, we find - for example on The Post - The claim of the new converts who are still demanding more, this time directed at younger women, presented in this case as victims of a shocking oversight. A bit like in 1994-95, when the federation of parents CIPF thundered with all his prestige to denounce secular stinginess of Douste-Blazy had miserably limited to classes of sixth obvious benefits of vaccination against hepatitis B: atmosphere [2] ... When will mammography teen?


Criteria intrinsic credibility

accordance with the methodology that visitors to this site begin to know, try to identify some intrinsic criteria which, even in a debate hypertechnique give the citizen the basic facts, easily verifiable by everyone and enabling it to regain some background information.

• According Roselyne Bachelot interviewed by Elle (08/10/10), "Breast cancer is one of my fights in public health. Early detection improves prognosis, facilitates the management and increases the chance of cure." Given the credibility of the Lady on assessment and, more generally, it belongs to the government regarding conflict of interest, we can already consider [3].

• Some 70 articles on the subject and obtained by tapping quickly on Google Actualitésen dated 10/10/2010, I found one referring to the drawbacks potential of such a screening. However, it is unusual for a social issue of interest, the dissenting opinions do not count for less than 2% of the vote. Even as crude hoaxes that H1N1, the percentage of citizens have fallen into the trap of promoting vaccination was around 10%: you say ...

• Even if (you wonder why), most of the relevant literature on the subject is in English, just anyone to enter - in French - on any search engine " Mammography and overdiagnosis "or" breast cancer and overdiagnosis "to see that things are far from being obvious. Why the official promotion of mammography does she no response to uncertainty as patent?

• For more than a year the visitors of this site have been initiated into the work of the Cochrane Foundation, which aims to take stock of available data on treatments or medical strategies. It turns out that the issue of mammography, the available data are so incompatible with the promotion of health authorities that, in an initiative unique to my knowledge, the review authors were keen to disseminate relevant in several languages a summary for use by laymen - which can be found attached to the French version. There is no need of having the faculty of medicine to show that the available evidence is hardly compatible with the promo without distinction of our minister of health ... It will include the authors ask exactly the question of the preceding paragraph, namely: how is it that it is so difficult for women covered by the current campaigns to be at least informed when the reserves yet many that can maintain in respect of screening and its presumed benefits?

• Even if we read a little English to go check the source [4], a recent article in the Los Angeles Times (04/10/10) identifies Astra Zeneca, one of the leading manufacturers of cancer (and currently sixth in global pharmaceutical company sales), behind the screening campaigns: interesting mix of genres, indeed ...


A little arithmetic

Designed to facilitate the representation of the player, the figures given below are theoretical, but can be made the basic problem (there are other more subtle issues, but it is important to prioritize the importance).
Imagine that historically (before any mammography procedure), the average age for diagnosis of breast cancer is 60 years old and still in average survival time after the diagnosis is 8 years ( is, therefore, death at an average age of 68 years).
Now, imagine that, through screening, diagnosis is advanced by three years, and is made on average at age 57.

• Even if this screening does not result in any benefit in terms of survival (age of death still 68 years) was mechanically increased the survival time of patients, since it is past 8 years (68 years - 60 years) to 11 years (68 years - 57 years) . A shot in the water? Not quite: 57 to 60 years, there has still lost 3 years of normal life and just send each (e) experience of the thing to compare three years of surgery / radiotherapy / chemotherapy in three years sweet unconsciousness - for a strictly no benefit in terms of life expectancy.

• Even better: imagine that as a result of such adverse effects of medical care "vigorous", the life expectancy of women screened and is shortened, and that they die, for example, the average age of 66 years. The zealots of testing - the same ones who confuse 94 million doses of vaccine useful with less than 10 million used [5] - can always argue that life expectancy after diagnosis increased from 8 to 9 years (66 years - 57 years ): The reality is that over time the "historic" pre-mammography where women with average die 68 years, they will now have an objective loss of hope life of two years ... All this, again, the price of suffering known cancer treatment ...
It has already taken a big step when these dear women we all love so as to give us a duty to urge routine screening have understood this reality simple arithmetic ...


Additional questions

In medicine, we often forget, the 100% does not exist: just as there is no drug is 100% effective, there is no of screening 100% reliable.

• With mammography, It will therefore be false negatives, ie women actually cancerous, not diagnosed as such and which, starting again with the false reinsurance mammography "normal" will appear soon to see again when this time clinical signs of disease . So that, paradoxically, the screening will be among them, contributed to delaying the diagnosis and treatment, which is all the more regrettable that the most explosive tumors - those most likely to win quickly a woman - are precisely those that can perfectly occur in the interval between mammograms [6].

• More importantly, there will be false positives, ie women who will end up with a diagnosis of cancer when they have none. Therefore, they will be embedded in a medicalization will be able to go, as appropriate, from simple biopsy (with all the anguish inherent) to surgery and treatment - with all its iatrogenic effects. The Cochrane review authors mentioned believe that a woman whose life expectancy will be extended (they do not say how much) by mammography, two hundred women will be victims of a false alarm and must go through additional tests (biopsie. ..) unnecessary anxiety and costly, while ten will not even get to see corrected this error in diagnosis and will be submitted - without any justification - to the joys known decaying surgery, radiotherapy and chemotherapy: it Just think of the friends in the position to represent the table ...

addition and certainly they can be cancerous, many breast tumors are developing extremely slow: so slow they would have remained silent throughout the life of affected women [6], some authors hesitate not to argue that some tumors may even spontaneously regress [7]. In other words, women will suffer the martyrdom of a cancer treatment for tumors in which they would never have heard all their lives.

other hand and although I have not seen any studies on this subject is a point that sometimes made me conscientious surgeons that certain tumors, a priori sensitive and as such assumed not pose a therapeutic problem appears to "burn" once they were made, as if the surgery had exacerbated the potential for exacerbation and dissemination: the situation is still regrettable if the tiny tumors in question were those that would have remained hidden had we not been teasing them with blows of the knife ... This, we repeat, simple individual comments, but could at least justify studies to examine the potential iatrogenic risk of surgery.

Finally, it is useful to recall that, in addition to its obvious disadvantages in terms of false positive mammograms - like any medical procedure - would deserve to see better evaluated its direct adverse effects: in addition to discomfort or pain (reported by many women), one can only wonder about the cumulative effects of repeated irradiation.


Summary

Under the influence of what can only be called a promotion rather systematically misleading women - especially those we love ... - Were taken to suggest that mammographic detection of a malignant tumor would "save lives". It is essentially false.

• In a given person, even if the cancer is real, the benefit of mammographic detection is marginal (compared to what would have happened if the cancer was detected clinically), if not infinitesimal: the most comprehensive reviews available on the subject (cf. PJ) estimates that only one woman in 2000 tested for ten years to escape death from cancer relative to those who have been out fishing rather than the radiologist. She did not say at all that the lucky winner will live longer and even specifies that no serious study can retain a benefit of screening in terms of overall survival: in other words, the lucky lady will die like the others - maybe even complications cancer treatment [8], or multiplication of mammograms triggered by the initial diagnosis of cancer ...

• For a lucky winner in 2000 women followed for 10 years, there will be ten times more miserable to be identified and treated incorrectly as cancer - and which, if any, will die of their cancer treatment .. . To put it another way: among all women who believe and claim that mammography "saved their life," the vast majority has no breast cancer and mammography them actually wasted life ... • Relatively

to his misfortune, to be considered almost as anecdotal the 200 women who are just terrified for a few weeks to several months until they are confirmed they have nothing in - after more or less traumatic biopsies and other tests delicious (and the If desired, then multiply the rate of mammograms "given the warning "...).


A who benefit from it?

• Clearly, it already enjoys in the lobby of radiologists - which is known to be powerful enough to us to make our country all-round champion of ultrasounds obstetric - a profit which is still awaiting the slightest proof.

• It also benefits the contemporary Narcissus [9], only too happy to reinforce his inability to think Being and tragic life in the illusion that we can "save his life" upon appointment, subject technical procedure reimbursed by the community ...

• This benefits, should be stressed, manufacturers of cancer drugs - both directly and indirectly. O Direct
, as we have seen, by multiplying the number of women unnecessarily exposed to long-term treatment, multiple and expensive.
o Indirectly, maintaining - again from public funds (through screening campaigns overly publicized, reinforced by patients' associations handled) - a general climate of fear that erodes the requirement of informed consent must yet to turn citizens into customers too docile to "cancer" innovative "whose superiority over older products and is cheaper, too, to show [10]. This benefits

• Finally, the "responsible" policies (pardon the oxymoron ...) and, again, in two ways.
o maintaining citizens through propaganda centered on pathologies very emotionally connoted (breast, prostate), in the sweet illusion that ensures their health, when - constantly aggravated by the irresponsibility of Parliamentarians and health administration - drug regulation is accelerating the on the drug marketing at best unnecessary and often overly toxic.
o diverting attention through the exhortation to individual responsibility, real public health problems which, in turn, report a much more political than personal initiative. To keep to that this related example: why breast cancer incidence has constantly increased over the decades? Who has effective means of governing the exposure of citizens to exogenous hormones, radiation, chemical pollutants and countless of which there are good reasons to think they could play a role in this modern epidemic?



Conclusion

At this stage of the information, it is unnecessary to go into finer detail assessments or controversy, I never argued, for example that assessments Cochrane were all that compelling or colleagues who think that mammography may be useful are necessarily thieves.
But even with vaccines against influenza [11] (and even more so given the potentially dire consequences iatrogenic campaigns mammography), the justification of this article is based on a clear statement already made by others [12] and it is hard to dispute: there is a shocking contrast between the evidence of a benefit to public health - which are nonexistent - and the immorality of the means used by health authorities, medical personnel or certain associations to convince people otherwise.


Dr. Marc Girard





---------------------------- -------------------------------------------------- -------



[1] "Stand up for the women you love," says a campaign spot.
[2] The laity are fanatical about the superiority they are formidable in good faith when they sacrifice to the fanaticism ...
[3] It is still possible to navigate with a compass that always points south: you just have to know ...
[4] Je traduis rapidement à destination des francophones obstinés : "If you look into their funding sources, you’ll often find a pharmaceutical company or device maker who stands to benefit from an expansion in the number of people with the condition." Welch calls AstraZeneca’s sponsorship of the awareness month "a huge conflict of interest," since encouraging women to get screened will invariably increase the number of breast cancer diagnoses and thus the market for their breast cancer drugs Arimidex, Faslodex, Nolvadex and Zoladex ("Si vous en venez aux sources de financement, vous trouverez souvent une firme pharmaceutique ou un fabricant de dispositif médical, qui ont tout à gagner d’une augmentation des gens concernés by the disease. "Welch [one of the experts interviewed by the newspaper] is sponsoring the month of information by Astra Zeneca for" a huge conflict of interest ", since that encouraging women to get tested will inevitably increase the number of breast cancers diagnosed and, thereby expanding the market for cancer of the firm, such as Arimidex, Faslodex, Nolvadex and Zoladex).
[5] When it is not their right with their left ...
[ 6] Esserman, L., Y. Shieh, and I. Thompson, Rethinking screening for breast cancer and prostate cancer. JAMA, 2009. 302 (15): p. 1685-92.
[7] Zahl, P.-H ., J. Maehlen, and HG Welch, The Natural History of Invasive Breast Cancers Detected by Mammography Screening. Arch Intern Med, 2008. 168 (21): p. 2311-2316.
[8] Black WC, Haggstrom DA, and HG Welch, All-cause Mortality in randomized trials of cancer screening. J Natl Cancer Inst, 2002. 94 (3): p. 167-73
[9] Lasch, C. The culture of narcissism. 1979: Flammarion (Champs trials).
[10] Garattini, S. and V. Bertele, Efficacy, safety, and cost of new anticancer drugs. BMJ, 2002. 325 (7358): p. 269-71.
[11] Compared to which, no offense to some users, I perfectly understand the difference between Efficacy and Effectiveness as meanings Cochrane reviews ...
[12] "The information provided by associations and governmental organizations is poor and severely biased in favor of screening. Few websites meet acceptable standards of informed consent in (...)". Jorgensen, KJ and Gotzsche PC, Presentation on websites of possible Benefits and Harms from screening for breast cancer: cross sectional study. BMJ, 2004. 328 (7432): p. 148


----------------------------------------------

--------------------------------------- Attachment to see Emergency: Brochure Cochrane



... must pass Knowledge and Truth ... ...
Truth always ends up Know ...


DJAMELITO


(Published by Authority, "My expertise is available to the public." Dr. Marc Girard)